JDRF

46 articles about JDRF

• JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community

  7/8/2020

  JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Tandem Diabetes Care (NASDAQ: TNDM), a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience, announce a new national partnership to help drive awareness and education on topics related to technology innovation, diabetes management, and healthcare for peo

• JDRF'S Virtual Imagine Gala One Hour/One Cause Raises Over $836,000 to Benefit Breakthrough Diabetes Research

  6/30/2020

  Bebe Rexha, JoJo, RaeLynn & Ozomatli Perform in Honor of JDRF's 50th Anniversary and 50 Years of T1D Breakthroughs Hosted by KTLA's Frank Buckley

• Game Over, T1D! Type 1 Diabetes Nonprofit JDRF Kicks Off Virtual Fundraising Campaign with 12-Hour Twitch Marathon on June 27

  6/26/2020

  JDRF, the leading global organization funding type 1 diabetes research, will hold a 12-hour charity fundraiser on Twitch this Saturday, June 27th to bring together people who have a common interest in livestreaming as well as a common goal: to put an end to type 1 diabetes.

• The JDRF House ParT1D for a Cure presented by Omnipod

  6/11/2020

  New virtual fundraiser unveiled in support of type 1 diabetes research On June 14th, the type 1 diabetes (T1D) community will take part in the JDRF House ParT1D for a Cure presented by Omnipod – Canada’s largest virtual house turning type one diabetes into type none. Despite the reality of physical distancing, this new, family-friendly virtual event will unite Canadians from coast to coast to get loud and raise critical funds for JDRF and its vita

• JDRF Names New Board Chair, Vice Chair

  2/20/2020

  NEW YORK , Feb. 20, 2020 /PRNewswire/ -- JDRF, a global leader in type 1 diabetes (T1D) research, today announced the appointment of two long-time volunteers to lead its International Board of Directors (IBOD). The two take office when the terms of current board leaders expire July 1, 2020 . JDRF's IBOD named Joseph P. Lacher, Jr. ,

• JDRF Reaches New Milestones in Work to Drive Cures for Type 1 Diabetes and Improve Lives

  2/14/2020

  Annual Report showcases year of advances, driven by $121.5 million in direct support and nearly $300 million in additional funding for T1D research

• Tidepool and JDRF Collaborate on Big Data Donation to Drive Diabetes Research

  2/13/2020

  Feb. 13, 2020 15:00 UTC Over 10,000 Donors Have Now Contributed to Tidepool's Big Data Donation Project PALO ALTO, Calif.--( BUSINESS WIRE )-- Tidepool, a 501(c)3 nonprofit committed to providing free software for the diabetes community, today announced a milestone for the Tidepool Big Data Donation Project, having delivered complete, longitudinal datasets from 300 unique individuals with type 1 diabetes (T1D) to eight JDRF-awarded research teams under signed license agreemen

• JDRF Recognizes NFL Superstars Who Help Drive Type 1 Diabetes Awareness Through The #MyCauseMyCleats Campaign

  12/10/2019

  The NFL My Cause, My Cleats campaign, now in its fourth year, allows players to design and wear specialized cleats to express their commitment and promote the causes that are most important to them.

• Type 1 Diabetes Champions Honored at Annual JDRF One Conference

  11/20/2019

  Lisa Wallack's contributions as a volunteer leader, both nationally and in New England, personifies invaluable commitment necessary to continue the push to find a cure for type 1 diabetes.

• JDRF Launches "T1D Champions. All Day. Every Day." Campaign for National Diabetes Awareness Month

  11/1/2019

  JDRF, the world's largest private funder of type 1 diabetes research, is commemorating National Diabetes Awareness Month this November by raising awareness of T1D and the urgent need to accelerate life-changing breakthroughs to cure, prevent, and treat T1D and its complications.

• 150 Youth with Type 1 Diabetes Selected to Participate in 2019 JDRF Children's Congress in Washington, D.C.

  6/20/2019

  JDRF, the leading global organization funding type 1 diabetes research, announced the selection of more than 150 youth delegates who will be traveling to Washington, D.C. for the JDRF 2019 Children's Congress from July 8-10.

• Sports and Entertainment Stars Converge on Capitol Hill to Advocate for Research Funding and Policies that Support the Type 1 Diabetes Community

  6/14/2019

  Celebrities join more than 160 youth Delegates at JDRF 2019 Children's Congress to meet with Congress

• TrialNet Announces Type 1 Diabetes Prevention Breakthrough--

  6/9/2019

  Immunotherapy delays diagnosis in people at high risk

• 

  Coalition of Cancer and Diabetes-Focused Nonprofits Addresses Rare Side Effect of Cancer Treatments

  5/30/2019

  About 1% of patients treated for cancer with checkpoint inhibitors can develop an autoimmune disease similar to Type 1 diabetes.
• 

  BioSpace Movers and Shakers: April 12

  4/12/2019

  Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.

• JDRF Board Appoints Leading Diabetes Researcher and Advocate Aaron J. Kowalski, Ph.D. as New President & CEO

  4/9/2019

  Internationally recognized diabetes expert, first JDRF CEO with T1D will lead next phase of focused effort to end type 1 diabetes

• JDRF Drives Next-Generation Type 1 Diabetes Research With New Partnerships & Breakthrough Science

  12/20/2018

  JDRF announced today that it made progressive advances this year on its path to a cure, funding new therapeutic developments to better treat the chronic autoimmune disease affecting 1.25 million Americans.

• JDRF Launches "I'm the Type" Campaign for National Diabetes Awareness Month

  11/1/2018

  JDRF is commemorating National Diabetes Awareness Month (NDAM) this November by raising awareness of T1D and the urgent need to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications.

• Sheku Kanneh-Mason To Join JDRF In The Fight Against Type 1 Diabetes

  9/13/2018

  JDRF names internationally renowned cellist as a global ambassador

• 

  SQZ Biotechnologies Closes Oversubscribed $72 Million Series C

  8/8/2018

  Watertown, Massachusetts-based SQZ Biotechnologies completed an oversubscribed Series C financing worth $72 million. New investors included Everblue, Illumina Ventures, Invus, Orient Life, and Viva Ventures Biotech Group.